CTS Retina

Home
CTS Retina

CTS Retina brings together a diverse group of retina experts from the world to discuss ongoing trials

14/01/2025

The suspense is over and we’re kicking off with a new location but the same mission of bringing the top clinician scientists, retinal specialists, and industry to discuss advances in clincial research and novel ideas.

Thrilled to announce the date of the 5th anniversary Clinical Trials at the Summit (CTS 2025) on June 21st, 2025 in Las Vegas, Nevada.

The meeting founder and co-chair Arshad M. Khanani, co-chairs, Peter Kaiser, Jeff Heier as well as the program committee - Anat Loewenstein, Frank G. Holz, SriniVas Sadda, Diana Do, David Boyer, MD are working on designing an interactive and innovative agenda for the meeting.

With the help of Medical Conference Planners International, we will execute another amazing meeting!

Please check the meeting website at ctsretina.org to access enduring content for the 2024 meeting and to stay updated on the upcoming CTS 2025!

08/08/2024

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Ramanath Bhandari, MD, FASRS, of RevOpsis Therapeutics discusses the development of RO-104 for the treatment of retinal disease.

08/08/2024

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Michael Singer, MD, of the University of Texas Health Science Center, discusses 36-month data investigating Yutiq for chronic noninfectious uveitis.

08/08/2024

CTS2024 took place two months ago, but the exciting update is that CTS 2025 is only 10 months away! Let's reminisce about CTS 2024 and the remarkable Champions of Retina Clinical Research. hashtag

Arshad Khanani Jeff Heier Peter Kaiser David Boyer, MD Diana Do Frank G. Holz Anat Loewenstein SriniVas Sadda Ramin Tadayoni

08/08/2024

🚨ICYMI🚨

Charles Semba, MD, of Eluminex Biosciences, discussed EB-105, trispecific antibody for that targets VEGF-A, VEGF-B, placental growth factor, angiopoietin-2 and interleukin-6 receptor, at . 🔗👇
CTS Retina
https://www.healio.com/news/ophthalmology/20240710/video-trispecific-antibody-has-multiple-targets-in-refractory-diabetic-macular-edema

08/06/2024

Meet the faculty for session #12: Gene Therapy and Optogenetics. Lejla Vajzovic, MD, FASRS will moderate a panel of investigators, clinician scientists, and industry and discuss PRISM, LUNA, and new entrants. We are excited to hear their insights on the future direction of this innovative and growing category in retina.

Panel: Mark Barakat, MD, Carl Danzig, Prof. Paulo Eduardo Stanga, Darin Curtiss, Peter Kaiser and Peter Francis, MD PhD

It's not too late to register for the virtual CTS meeting. P.S. It's complimentary for physicians, fellows, and residents!

07/06/2024

Meet the faculty for session #11: Designing Registration Trials with the Latest FDA Guidance. As part of their commitment to drug safety and efficacy, the FDA and its leadership have a long-standing history of being accessible to sponsors and physicians to accelerate innovation. Novel MOAs and investigational drugs may require sponsors to develop new regulatory endpoints and clinical trial designs. Peter Kaiser will lead the discussion with Arshad M. Khanani, Robert Kim, Eliot Lazar, Jennifer Lim, raj maturi, Steve Pakola, MD and Adam Turpcu on new FDA draft guidance and what it means for the regulatory environment.

07/06/2024

Meet the faculty for session #10: Clinical Trails Addressing nAMD. Anat Loewenstein moderates with panelists Robert Avery, Lejla Vajzovic, MD, FASRS, Megan Baldwin, Victor Perlroth, and Carl Regillo, MD. The panel will discuss going beyond VEGF-A with targets VEGF-C/D, the current standard of care, and results/updates on HELIOS, DAVIO2, ODYSSEY, NORSE trials.

To register for this session, visit www.ctsretina.org

06/06/2024

Meet the Faculty for session #9: Retina Innovation 2024 and Beyond - An Investor View. Join Ram Palanki as he moderates a candid discussion gathering insights from analysts, investors, and industry leaders. Panelists include Matthew Caufield, Emmett Cunningham, Anupam Dalal, Aaron Osborne, Ronil Patel, Kim Smith and Gena Wang.

You can view this session on live stream by registering at ctsretina.org.

06/06/2024

The Clinical Trials at the Summit (CTS) 2024 event starts in just two days. The virtual platform for CTS 2024 is now accessible for download for registered attendees. Prepare to engage with fellow attendees, both in-person and virtually, explore the program, take part in polls, and enjoy other interactive activities. For a complimentary registration, visit ctsretina.org, available to all practicing physicians, fellows, and residents!

.

Healio | Ocular Surgery News

06/06/2024

Meet the faculty for session #8: Clinical Trials Utilizing Surgical Delivery, Devices and Home OCT. Christina Weng will moderate a lively discussion with Thomas Aaberg Jr, Veeral Sheth, MD, MBA, FASRS, Chirag Jhaveri, Carlos Quezada Ruiz, David RP Almeida MD MBA PhD and Jeff Heier. This session will explore gene therapy, delivery platforms, patient impact on home OCT and DRCR retina network protocol AO.

This is a 'do-not-miss' session! Visit www.ctsretina.org to sign up and attend this session and more.

Address

84060, 84068, 84098

Website

https://www.ctsretina.org/

Alerts

Be the first to know and let us send you an email when CTS Retina posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CTS Retina:

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City:

14/01/2025

08/08/2024

08/08/2024

08/08/2024

08/08/2024

08/06/2024

07/06/2024

07/06/2024

06/06/2024

06/06/2024

06/06/2024

Address

Website

Alerts

Contact The Practice

Shortcuts

Share